Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STereotactic Body Radiotherapy (SBRT) After oligoprogRession Metastatic Breast Cancer (STAR-B)

NCT06489821 is registered in ClinicalTrials.gov with Juravinski Cancer Center as lead sponsor.

NCT NCT06489821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06489821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STereotactic Body Radiotherapy (SBRT) After oligoprogRession Metastatic Breast Cancer (STAR-B)
Lead sponsor
Juravinski Cancer Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2024
Completion date
December 31, 2027
Enrollment
36 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer, oligoprogression